Litcius/Paper detail

Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation

Wei Yan, Lingtian Zhang, Fengping Lv, Marialuisa Moccia, Francesca Carlomagno, Christophe Landry, Massimo Santoro, Fabien Gosselet, Brendan Frett, Hongyu Li

2021European Journal of Medicinal Chemistry26 citationsDOIOpen Access PDF

Topics & Concepts

Trk receptorTropomyosin receptor kinase AChemistryCancer researchTropomyosinKinaseCell cultureCancerColorectal cancerPharmacologyInternal medicineReceptorNeurotrophinBiochemistryMedicineBiologyGeneticsMyosinMelanoma and MAPK PathwaysQuinazolinone synthesis and applicationsCytokine Signaling Pathways and Interactions
Discovery of pyrazolo-thieno[3,2-d]pyrimidinylamino-phenyl acetamides as type-II pan-tropomyosin receptor kinase (TRK) inhibitors: Design, synthesis, and biological evaluation | Litcius